Black Hawk Acquisition CORP 10-K annual reports

Black Hawk Acquisition Corporation has filed an amendment to its 2025 annual report, primarily to include its adopted Compensation Recovery (Clawback) Policy.

Black Hawk Acquisition Corporation reported its fiscal year 2025 results, revealing a definitive business combination agreement with Vesicor Therapeutics, Inc. but also significant going concern uncertainties and internal control weaknesses.

Black Hawk Acquisition Corporation files an amendment to its annual report on Form 10-K to include the Executive Compensation Recovery Policy (Clawback Policy) that was inadvertently omitted in the original filing.

Black Hawk Acquisition Corporation's Form 10-K reveals a net income of $1,915,703 for fiscal year 2024 but raises substantial doubt about its ability to continue as a going concern due to recurring losses and a net capital deficiency.